Tania Mara Welzel
Geboren:
1974
Hat mitgewirkt an:
-
Epidemiology and risk factors for primary liver cancer : hepatocellular carcinoma and intrahepatic cholangiocarcinoma
-
Assessing patient preferences for treatment decisions for new direct acting antiviral (DAA) therapies for chronic hepatitis C virus infections
-
Etablierung eines experimentellen Systems für die stabile Expression hantaviraler Nukleokapsidproteine in Säugetierzellen
-
Adherence to pan‐genotypic glecaprevir/pibrentasvir and efficacy in HCV‐infected patients: A pooled analysis of clinical trials